Post-approval studies (Phase 4)Ended earlyNCT02940691What this trial is testingScale-up of Treatment of Hepatitis C Infection Among People Who Inject DrugsWho this might be right forHepatitis C Kirby Institute 32
Not applicableWithdrawnNCT00571714What this trial is testingPilot Comparison of Standard Antiviral Therapy With and Without 12 Weeks of Betaine in Genotype 1 Naive PatientsWho this might be right forChronic Hepatitis C University of Nebraska
Post-approval studies (Phase 4)Ended earlyNCT00255008What this trial is testingPeg-Intron and Rebetol Therapy in Treatment of Naive Hepatitis C Patients: A Comparison of Race and Genotype on Treatment Outcome (Study P04212)Who this might be right forHepatitis C, Chronic Merck Sharp & Dohme LLC 121
Testing effectiveness (Phase 2)UnknownNCT00332176What this trial is testingEvaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis CWho this might be right forChronic Hepatitis C BioWest Therapeutics Inc 50
Testing effectiveness (Phase 2)UnknownNCT01272310What this trial is testingClinical Trial to Assess Safety and Efficacy of Combination Therapy: Hydroxychloroquine, Pegylated Interferon Alpha-2a and Ribavirin in Chronic Hepatitis C Subjects Non-responders to the Standard of Care Therapy.Who this might be right forChronic Hepatitis C Sheba Medical Center 36
Testing effectiveness (Phase 2)Study completedNCT00157534What this trial is testingEvaluate the Safety and Efficacy of Celgosivir in Patients With Chronic Hepatitis C Genotype 1 InfectionWho this might be right forHepatitis C, Chronic BioWest Therapeutics Inc 43
Post-approval studies (Phase 4)Ended earlyNCT01467492What this trial is testingTelaprevir, Peg-IFN-alfa-2a, and RBV in Treatment-Experienced Black/African American and Non-Black/African American Subjects With Genotype 1 Chronic Hepatitis CWho this might be right forHepatitis C Vertex Pharmaceuticals Incorporated 121
Testing effectiveness (Phase 2)Study completedNCT01225380What this trial is testingResponse-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis CWho this might be right forChronic Hepatitis C Infection Gilead Sciences 324
Post-approval studies (Phase 4)Study completedNCT00910975What this trial is testingIndividualized Duration of Peg-interferon/Ribavirin Treatment of Hepatitis CWho this might be right forChronic Hepatitis C, Genotype 1 Göteborg University 100
Testing effectiveness (Phase 2)Study completedNCT00980330What this trial is testingA Safety and Effectiveness Study of TMC435 in Chronic, Genotype 1, Hepatitis C Patients Who Failed to Previous Standard TreatmentWho this might be right forHepatitis C Tibotec Pharmaceuticals, Ireland 463
Large-scale testing (Phase 3)Study completedNCT02399345What this trial is testingOmbitasvir/Paritaprevir/Ritonavir and Dasabuvir Co-Administered With Sofosbuvir With and Without Ribavirin in Treatment-Naive HCV Genotype 1-Infected AdultsWho this might be right forChronic Hepatitis C Virus (HCV Infection Genotype 1) AbbVie 10
Testing effectiveness (Phase 2)Study completedNCT00217139What this trial is testingEvaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 InfectionWho this might be right forHepatitis C, Chronic BioWest Therapeutics Inc 60
Testing effectiveness (Phase 2)Study completedNCT01903954What this trial is testingSetrobuvir in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients With Genotype 1 Chronic Hepatitis CWho this might be right forHepatitis C, Chronic Hoffmann-La Roche 283
Testing effectiveness (Phase 2)UnknownNCT01335711What this trial is testingCHRONVAC-C Study Followed by Standard of Care in Chronic Hepatitis C Virus (HCV) SubjectsWho this might be right forChronic Hepatitis C ChronTech Pharma AB 32
Testing effectiveness (Phase 2)Study completedNCT00446134What this trial is testingTaribavirin Phase 2 Dose Finding Study for the Treatment of Hepatitis C Virus (HCV)Who this might be right forChronic Hepatitis C Bausch Health Americas, Inc. 278
Not applicableStudy completedNCT02581163What this trial is testingEffectiveness of Paritaprevir/Ritonavir - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in BelgiumWho this might be right forChronic Hepatitis C, Genotype 1 or 4 AbbVie 314
Large-scale testing (Phase 3)Study completedNCT00265395What this trial is testingExtended Treatment With PEG-Intron® and Rebetol® in Patients With Genotype 1 Chronic Hepatitis C and Slow Virologic Response (Study P03685)Who this might be right forHepatitis C, Chronic Merck Sharp & Dohme LLC 1,428
Testing effectiveness (Phase 2)Study completedNCT01030432What this trial is testingStudy of BMS-650032 With Peginterferon Alfa-2a Plus RibavirinWho this might be right forHepatitis C Virus Bristol-Myers Squibb 285
Testing effectiveness (Phase 2)Study completedNCT00517439What this trial is testingHepatitis C Virus (HCV) Polymerase Inhibitor Pro-Drug in Combination With PEGASYS Plus COPEGUS Compared With PEGASYS Plus COPEGUS in Patients With Chronic Hepatitis C Genotype 1 Infection.Who this might be right forHepatitis C, Chronic Hoffmann-La Roche 516
Not applicableStudy completedNCT02725866What this trial is testingReal World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Participants With Chronic Hepatitis CWho this might be right forChronic Hepatitis C AbbVie 216